Women who undergo aggressive surgery for breast cancer may miss more work

October 09, 2017

A new study reveals that patients with breast cancer who received more aggressive treatments were more likely to experience disruptions in employment. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may be helpful for patients who are comparing their options for breast cancer treatment.

Many women with breast cancer are working at the time of diagnosis and would benefit from understanding how their treatment decisions might affect their employment. To examine how employment experiences are impacted by different types of breast cancer treatment, Reshma Jagsi, MD, DPhil, of the University of Michigan, and her colleagues surveyed women aged 20 to 79 years diagnosed with stages 0-II breast cancer as reported to the Georgia and Los Angeles SEER registries in 2014 and 2015. The investigators analyzed 1006 women who were reportedly working before their diagnosis.

Among the surveyed women, 62 percent underwent lumpectomy to remove their tumors, 16 percent had unilateral mastectomy (8 percent with reconstruction), and 23 percent had bilateral mastectomy (19 percent with reconstruction). One-third of women received chemotherapy. Most (84 percent) worked full time before diagnosis.

The study's findings also revealed that women who underwent bilateral mastectomy with reconstruction had nearly eight times the risk of missing over a month of work, as compared with those who underwent lumpectomy. Also, women who missed more than a month of work often lost substantial income; 29 percent of these women lost more than $5000.

"Prior studies have shown that most of the women who had bilateral mastectomy could have chosen lumpectomy but chose the more aggressive surgery, often out of a desire to improve peace of mind. This study helps to quantify the impact of this decision on the employment and financial experiences of those women soon after diagnosis," said Dr. Jagsi. "The impact of treatment on employment and finances is a consideration that women may wish to take into account when weighing the pros and cons of various surgical options they are considering."
-end-
Additional Information

Full Citation: "Treatment decisions and the employment of breast cancer patients: results of a population-based survey." Reshma Jagsi, Paul Abrahamse, Kamaria L. Lee, Lauren P. Wallner, Nancy K. Janz, Ann S. Hamilton, Kevin C. Ward, Monica Morrow, Allison W. Kurian, Christopher R. Friese, Sarah T. Hawley,and Steven J. Katz. CANCER; Published Online: October 9, 2017 (DOI: 10.1002/cncr.30959).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.30959

Author Contact: Jessica Webster or Nicole Fawcett, at the University of Michigan Comprehensive Cancer Center's communications office, at jeswebst@med.umich.edu or nfawcett@med.umich.edu.

About the Journal

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online at http://wileyonlinelibrary.com/journal/cancer.

Follow us on Twitter @JournalCancer and Facebook https://www.facebook.com/ACSJournals

About Wiley

Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.

Wiley

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.